Navigation Links
The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists

Beta-agonists are group A substances of the European guideline 93/257/EWG (revision 98/536/EG) having an anabolic effect and not licensed. Thus, they have to be determined in veterinarian samples like muscle, liver, retina, and urine. The coupling of High Pressure Liquid Chromatography (HPLC) and Electrospray Ionization Tandem Mass Spectrometry (ESI-MS-MS) seems to be the analytical method of choice for such thermally labile and polar substances. Classical HPLC/ESI-MS-MS instrumentation allows the determination with satisfying detection limits, accuracy, and reproducibility. Due to the high number of substances that have to be analyzed in a single run, longer chromatographic separation times have to be accepted. Monolithic columns are made of a single piece of porous silica with a defined pore structure. Thus, lower back pressure in the column allows the use of higher flow rates and flow gradients, without loss in chromatographic resolution. In the following work the possibility of increasing sample throughput and sensitivity using monolithic columns at higher flow rates and a modern mass spectrometer, which is optimized to work with such high flow rates is evaluated.

High Pressure Liquid Chromatography

: Agilent 1100 series binary pump, column oven, and well-plate autosampler

columns: Inertsil ODS-3 150x2.1 mm at a flow rate of 200 μL/min Merck Chromolith SpeedROD RP-18e 50x4.6 mm at flow rates of 1000 μL/min and 2000 μL/min

eluent A: H2O+5mM NH4formiate pH=4.0 eluent B: acetonitrile+5% H2O

gradients (A/B):

column oven temperature of 25C

injection of 20 μl Mass Spectrometry:

Applied Biosystems API 4000 LC/MS/MS System with Turbo V source in positive ion mode 500C at 200 μl/min 700C at 1000 and 2000 μl/min (without split)

detection of 46 MRMs in 3 periods using dwell times of 50-120 ms dependent on flow rate

2 to 3 internal standards were used in each period

Determination of group A substances

For doubtless determination of betaagonists, 4 identification points have to be achieved (guideline 93/256/EWG). That means in case of HPLC/MS/MS 2 MRMs (1 precursor ion and two product ions) have to be measured. The ratio of quantifier and qualifier MRM must be stable with a tolerance of 20 to 50% independent of relative intensity. Retention times must be higher than 2 times of the dead volume of the column and relative retention times are allowed to shift by 2.5%.

Results

By using monolithic columns at higher flow rates, the time for analysis can be reduced drastically (Figures 1-3). At flow rates below 1000 μL/min peak shape on this column is not satisfying (not shown). In the case of analysed -agonists the time of analysis dropped from 43 minutes to 15 minutes (1000 μL/min) or 8 minutes (2000 μL/min), respectively, including equilibration time (Figure 4). Due to optimised gas streams in the ion source and the possibilities of using higher temperatures for evaporation, similar or even lower limits of detection (LOD) were achieved for analyzed compounds at 1000 μL/min (Table). Little loss of sensitivity must be tolerated when flow rates of 2000 μL/min or higher are used. LODs of 1000 and 2000 μL/min are comparable when compounds elute with higher organic content due to easier evaporation of such solvents.


'"/>

Source:


Page: All 1 2

Related biology technology :

1. Generate Adenovirus Vectors in E. coli by Homologous Recombination with the AdEasy Adenoviral Vector System
2. HPLC/MS/MS Analysis of Bitter Acids in Hops and Beer
3. Determination of Polar Organophosphorus Pesticides in Aqueous Samples by Direct Injection Using HPLC/MS/MS
4. Detection of nitrofurane metabolites in food with HPLC/MS/MS
5. High-throughput gene expression analysis to screen for anti-asthma drugs
6. DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid DNA purification
7. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
8. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
9. A highly sensitive ATP-luminescence assay using VICTOR2 with the dispenser option
10. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
11. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... , ... October 12, 2017 , ... ... with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of ... trends in analytical testing are being attributed to new regulatory requirements for all ...
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):